| Followers | 967 |
| Posts | 387456 |
| Boards Moderated | 0 |
| Alias Born | 06/24/2011 |
Wednesday, January 12, 2022 11:54:43 AM
Adi Zuloff-Shani, PhD, Chief Technologies Officer of SciSparc, stated, "We have been tracking the research in psychedelics and are encouraged by the reports which appear to be favorable, particularly for disorders of the central nervous system. I expect our approach has the potential to be compatible with psychedelic compounds, so it behooves us to include them in the pool of candidates we consider when evaluating new opportunities."
SPRC
SPRC
Recent SPRC News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:16:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/11/2026 12:00:15 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 08:20:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/16/2026 08:01:17 PM
- SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy • GlobeNewswire Inc. • 03/16/2026 12:20:00 PM
- Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy • GlobeNewswire Inc. • 03/13/2026 11:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/12/2026 08:41:52 PM
- SciSparc’s NeuroThera Labs reports publication of international patent application • IH Market News • 03/12/2026 03:45:54 PM
- ciSparc’s NeuroThera Labs reports publication of international patent application • IH Market News • 03/12/2026 03:45:54 PM
- SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease • GlobeNewswire Inc. • 03/12/2026 11:55:00 AM
- SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails • GlobeNewswire Inc. • 03/10/2026 01:28:00 PM
- Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease • GlobeNewswire Inc. • 03/10/2026 12:59:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/02/2026 01:08:01 PM
- SciSparc Announces 1-for-9 Reverse Share Split • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 02/17/2026 10:27:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/17/2026 09:01:20 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/12/2026 09:02:11 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 09:01:15 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 02/03/2026 09:36:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/02/2026 09:01:10 PM
